SlideShare a Scribd company logo
CLINICAL EVALUATION
Recent amendments made to the Medical Device Directive (MDD 93/42/EEC) state that every
medical device affixing CE Logo, regardless of its classification, must have a clinical evaluation
report in its Technical File / Design Dossier.
The Directive’s specific focus on implantable or class III medical devices gives the false
impression that clinical investigation does not apply to other Medical devices. This has led to
the current situation where clinical trials are rarely done in the pre-market steps of medical
devices development.
With the implementation of Directive 2007/47/EC, clinical evaluation has become a central
element of regulatory compliance under the Medical Device Directive and Active Implantable
Medical Device Directive.
Manufacturers of innovative technologies face the greatest impact, as they must present
complete and sufficient clinical evaluation files to ensure timely assessment and favourable
review of their products.
BENEFITS OF CONDUCTING CLINICAL EVALUATION
Regulatory conformance: Conforming to the regulatory framework is necessary and should
be done in order to get Notified Body approval for Technical file followed by CE Certification.
Choosing to perform a clinical investigation is the best answer to conform to the new
requirements of the Medical Device Directive MDD 93/42/EEC.
Early detection and resolution of safety issues: Over 25% of safety alerts are due to
manufacturing defects. This high proportion demonstrates the importance of an early
detection of potential safety issues. Early assessment gives the manufacturer time to take
corrective action and to provide potential damages to the company’s reputation.
Manufacturer Image: An early clinical investigation most often results in a positive image and
greater usage of the product throughout the healthcare system. A well-designed clinical
investigation based on a robust methodology gives a chance to publish a scientific article in a
peer-reviewed journal.
HOW TO FOLLOW STANDARD REQUIRMENT
METHODOLOGY WHEN PERFORMING A CLINICAL EVALUATION
The most important part lies in the methodology used. Any evaluation must be conducted
following a strict adherence to regulatory requirements is the success of the clinical study. A
proper methodology saves lot of time and success.
APPOINT I 3 CONSULTING FOR BETTER NAVIGATION AND RESULTS
Working early with I 3 Consulting for smooth and error free submission to Notified Bodies.
Our project manager’s work with clients to ensure clinical evaluation was adequate and in
line with intended use, labelling, equivalent devices and in conformance with MEDDev
Guidelines.
CLINICAL
EVALUATION
ANALYSIS OF CLINICIAL DATA by
(a) Clinical investigation(s) of the device concerned
(b) Studies reported in the scientific literature of a
similar device
(c) Published and/or unpublished reports on other
clinical experience of either the device in question
or a similar device
POST MARKET
a) Surveillance (PMS)
b) Clinical Follow-up (PMCF)
c) Residual Risk
KNOW OUR FEES
Complete our Quote Request Form for a detailed proposal. For more urgent requests, feel
free to use our Website Skype link or direct dialling numbers to USA & India.
Activity
Class of Medical Device
1 1s/m 11a 11b 111
Guidance on MDD Requirements $ 50 $ 100 $ 150 $ 200 $ 250
Development of Protocol / Procedure $ 50 $ 50 $ 50 $ 50 $ 50
Clinical Evaluation & Documentation $ 300 $ 400 $ 500 $ 600 $ 700
Post Market Surveillance Procedure & Plan $ 100 $ 150 $ 200 $ 250 $ 300
Post Market clinical follow-up Procedure & Plan $ 100 $ 150 $ 200 $ 250 $ 300
GAP Analysis of Risk Management File $ 100 $ 150 $ 200 $ 250 $ 300
Vigilance Control & Related Forms $ 100 $ 100 $ 100 $ 100 $ 100
Taxes Extra
GET A CUSTOMIZED PROPOSAL
Complete our Quote Request Form for a detailed proposal. For more urgent requests, feel
free to use our Website Skype link or direct dialling numbers to USA & India.
CONTACT INFORMATION
INDIA
S8, J J PARK 02, 4 CROSS, BHAVANI NAGAR,
CHRIST SCHOOL ROAD, S.G PALYA,
BANGALORE – 560029
FAX + 91 804 160 8963
USA
2871 COASTAL DRIVE, AURORA mail to us
ILLINOIS – 60503
FAX + 1 815 986 2632
www.i3cglobal.com
TURKEY
ANADOLU BULVARI GIMAT SITESI 3. BLOCK NO: 29
P06105 MUCUNKOY, ANKARA, TURKEY
FAX + 90 312 397 0058

More Related Content

What's hot

Premarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposalPremarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposal
Annet Visscher
 
Clinical Evaluation Report (CER) - Decode the Step-wise Approach for Compliance
Clinical Evaluation Report (CER) - Decode the Step-wise Approach for ComplianceClinical Evaluation Report (CER) - Decode the Step-wise Approach for Compliance
Clinical Evaluation Report (CER) - Decode the Step-wise Approach for Compliance
Freyr Solutions
 
Summary of MEDDEV 2.7.1 rev 4
Summary of MEDDEV 2.7.1 rev 4Summary of MEDDEV 2.7.1 rev 4
Summary of MEDDEV 2.7.1 rev 4
Keith Morel
 
Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices
Arete-Zoe, LLC
 
Post Market Clinical Surveillance, Experience of the Industry by S. Menzl - ...
Post Market Clinical Surveillance,  Experience of the Industry by S. Menzl - ...Post Market Clinical Surveillance,  Experience of the Industry by S. Menzl - ...
Post Market Clinical Surveillance, Experience of the Industry by S. Menzl - ...
qserveconference2013
 
clinical-evaluation-report (CER)
clinical-evaluation-report (CER)clinical-evaluation-report (CER)
clinical-evaluation-report (CER)
PEPGRA Healthcare
 
MedDRA Coding - Katalyst HLS
MedDRA Coding - Katalyst HLSMedDRA Coding - Katalyst HLS
MedDRA Coding - Katalyst HLS
Katalyst HLS
 
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra HealthcareClinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
PEPGRA Healthcare
 
Presentation: Life cycle of medical devices
Presentation: Life cycle of medical devicesPresentation: Life cycle of medical devices
Presentation: Life cycle of medical devices
TGA Australia
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018
Bhaswat Chakraborty
 
Medical Product Development cycle
Medical Product Development cycleMedical Product Development cycle
Medical Product Development cycle
max hanafi
 
Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qs...
Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qs...Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qs...
Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qs...
qserveconference2013
 
FDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic testsFDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic tests
MaRS Discovery District
 
Presentation: Draft Clinical Evidence Guidelines – Medical Devices
Presentation: Draft Clinical Evidence Guidelines – Medical DevicesPresentation: Draft Clinical Evidence Guidelines – Medical Devices
Presentation: Draft Clinical Evidence Guidelines – Medical Devices
TGA Australia
 
"Medical Device Regulation, A Delicate Balance, An Evolving Process: What doe...
"Medical Device Regulation, A Delicate Balance, An Evolving Process: What doe..."Medical Device Regulation, A Delicate Balance, An Evolving Process: What doe...
"Medical Device Regulation, A Delicate Balance, An Evolving Process: What doe...
MedTech
 
Presentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesPresentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence Guidelines
TGA Australia
 
New European Medical Device Regulations: Keeping Your Orthopaedic and Spine ...
New European Medical Device Regulations:  Keeping Your Orthopaedic and Spine ...New European Medical Device Regulations:  Keeping Your Orthopaedic and Spine ...
New European Medical Device Regulations: Keeping Your Orthopaedic and Spine ...
April Bright
 
Medical Device Product Development
Medical Device Product DevelopmentMedical Device Product Development
Medical Device Product Development
EMMAIntl
 
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trials Des...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trials Des...FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trials Des...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trials Des...
MedicReS
 
20210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr202120210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr2021
Annet Visscher
 

What's hot (20)

Premarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposalPremarket Clinical Evaluation under the EU MDR proposal
Premarket Clinical Evaluation under the EU MDR proposal
 
Clinical Evaluation Report (CER) - Decode the Step-wise Approach for Compliance
Clinical Evaluation Report (CER) - Decode the Step-wise Approach for ComplianceClinical Evaluation Report (CER) - Decode the Step-wise Approach for Compliance
Clinical Evaluation Report (CER) - Decode the Step-wise Approach for Compliance
 
Summary of MEDDEV 2.7.1 rev 4
Summary of MEDDEV 2.7.1 rev 4Summary of MEDDEV 2.7.1 rev 4
Summary of MEDDEV 2.7.1 rev 4
 
Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices
 
Post Market Clinical Surveillance, Experience of the Industry by S. Menzl - ...
Post Market Clinical Surveillance,  Experience of the Industry by S. Menzl - ...Post Market Clinical Surveillance,  Experience of the Industry by S. Menzl - ...
Post Market Clinical Surveillance, Experience of the Industry by S. Menzl - ...
 
clinical-evaluation-report (CER)
clinical-evaluation-report (CER)clinical-evaluation-report (CER)
clinical-evaluation-report (CER)
 
MedDRA Coding - Katalyst HLS
MedDRA Coding - Katalyst HLSMedDRA Coding - Katalyst HLS
MedDRA Coding - Katalyst HLS
 
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra HealthcareClinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
Clinical evaluation report cer in a more stringent regulatory- Pepgra Healthcare
 
Presentation: Life cycle of medical devices
Presentation: Life cycle of medical devicesPresentation: Life cycle of medical devices
Presentation: Life cycle of medical devices
 
Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018Clinical Trial Requirements Medical Devices 27 dec2018
Clinical Trial Requirements Medical Devices 27 dec2018
 
Medical Product Development cycle
Medical Product Development cycleMedical Product Development cycle
Medical Product Development cycle
 
Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qs...
Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qs...Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qs...
Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qs...
 
FDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic testsFDA’s approach to regulation of in vitro diagnostic tests
FDA’s approach to regulation of in vitro diagnostic tests
 
Presentation: Draft Clinical Evidence Guidelines – Medical Devices
Presentation: Draft Clinical Evidence Guidelines – Medical DevicesPresentation: Draft Clinical Evidence Guidelines – Medical Devices
Presentation: Draft Clinical Evidence Guidelines – Medical Devices
 
"Medical Device Regulation, A Delicate Balance, An Evolving Process: What doe...
"Medical Device Regulation, A Delicate Balance, An Evolving Process: What doe..."Medical Device Regulation, A Delicate Balance, An Evolving Process: What doe...
"Medical Device Regulation, A Delicate Balance, An Evolving Process: What doe...
 
Presentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence GuidelinesPresentation: Clinical Evidence Guidelines
Presentation: Clinical Evidence Guidelines
 
New European Medical Device Regulations: Keeping Your Orthopaedic and Spine ...
New European Medical Device Regulations:  Keeping Your Orthopaedic and Spine ...New European Medical Device Regulations:  Keeping Your Orthopaedic and Spine ...
New European Medical Device Regulations: Keeping Your Orthopaedic and Spine ...
 
Medical Device Product Development
Medical Device Product DevelopmentMedical Device Product Development
Medical Device Product Development
 
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trials Des...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trials Des...FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trials Des...
FDA 2013 Clinical Investigator Training Course: Issues in Clinical Trials Des...
 
20210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr202120210413 nvfg acs iso14155 13_apr2021
20210413 nvfg acs iso14155 13_apr2021
 

Similar to Clinical Evaluation of Medical Devices

MedAccred Welcome Pack V13 160920
MedAccred Welcome Pack V13 160920MedAccred Welcome Pack V13 160920
MedAccred Welcome Pack V13 160920
Adrien Boespflug
 
Quality & compliance excellence in pharmaceuticals
Quality & compliance excellence in pharmaceuticalsQuality & compliance excellence in pharmaceuticals
Quality & compliance excellence in pharmaceuticals
Anvita Bharati
 
Agenda 6th Annual Diagnostic QA Conference
Agenda 6th Annual Diagnostic QA ConferenceAgenda 6th Annual Diagnostic QA Conference
Agenda 6th Annual Diagnostic QA Conference
Rachel Starnes
 
Clinical Research Org. Intensifies Compliance by Automating Audit & CAPA
Clinical Research Org. Intensifies Compliance by Automating Audit & CAPA Clinical Research Org. Intensifies Compliance by Automating Audit & CAPA
Clinical Research Org. Intensifies Compliance by Automating Audit & CAPA
MetricStream Inc
 
Developing Product Requirements For Medical Devices
Developing Product Requirements For Medical DevicesDeveloping Product Requirements For Medical Devices
Developing Product Requirements For Medical Devices
Walt Maclay
 
Oshas guidelines, NABL certification & Accrediation, CFR 21 part11 , WHO- GMP...
Oshas guidelines, NABL certification & Accrediation, CFR 21 part11 , WHO- GMP...Oshas guidelines, NABL certification & Accrediation, CFR 21 part11 , WHO- GMP...
Oshas guidelines, NABL certification & Accrediation, CFR 21 part11 , WHO- GMP...
bhaktivk9765
 
Demo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre AccreditationDemo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre Accreditation
Global Manager Group
 
Qa tools and techniques
Qa tools and techniquesQa tools and techniques
Qa tools and techniques
prashik shimpi
 
concept of validation
concept of validationconcept of validation
concept of validation
prashik shimpi
 
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
Marcep Inc.
 
Scott Buchheit RA Specialist Resume
Scott Buchheit RA Specialist ResumeScott Buchheit RA Specialist Resume
Scott Buchheit RA Specialist Resume
Scott Buchheit
 
The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011
The MarkeTech Group
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
Jacobe2008
 
Managing Reliability Expectations & Warranty Costs in Medical Electronics
Managing Reliability Expectations & Warranty Costs in Medical ElectronicsManaging Reliability Expectations & Warranty Costs in Medical Electronics
Managing Reliability Expectations & Warranty Costs in Medical Electronics
Cheryl Tulkoff
 
Critical Path Initiative Challenges
Critical  Path  Initiative  ChallengesCritical  Path  Initiative  Challenges
Critical Path Initiative Challenges
Landmark
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Covance
 
Quality Management Systems (2).pdf
Quality Management Systems (2).pdfQuality Management Systems (2).pdf
Quality Management Systems (2).pdf
tejas359590
 
Four Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialFour Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device Trial
David Levin
 
Introduction to validation
Introduction to validationIntroduction to validation
Introduction to validation
SachinkumarBhairagon
 
FDA Guidance and Clinical Trials
FDA Guidance and Clinical TrialsFDA Guidance and Clinical Trials
FDA Guidance and Clinical Trials
AG Mednet
 

Similar to Clinical Evaluation of Medical Devices (20)

MedAccred Welcome Pack V13 160920
MedAccred Welcome Pack V13 160920MedAccred Welcome Pack V13 160920
MedAccred Welcome Pack V13 160920
 
Quality & compliance excellence in pharmaceuticals
Quality & compliance excellence in pharmaceuticalsQuality & compliance excellence in pharmaceuticals
Quality & compliance excellence in pharmaceuticals
 
Agenda 6th Annual Diagnostic QA Conference
Agenda 6th Annual Diagnostic QA ConferenceAgenda 6th Annual Diagnostic QA Conference
Agenda 6th Annual Diagnostic QA Conference
 
Clinical Research Org. Intensifies Compliance by Automating Audit & CAPA
Clinical Research Org. Intensifies Compliance by Automating Audit & CAPA Clinical Research Org. Intensifies Compliance by Automating Audit & CAPA
Clinical Research Org. Intensifies Compliance by Automating Audit & CAPA
 
Developing Product Requirements For Medical Devices
Developing Product Requirements For Medical DevicesDeveloping Product Requirements For Medical Devices
Developing Product Requirements For Medical Devices
 
Oshas guidelines, NABL certification & Accrediation, CFR 21 part11 , WHO- GMP...
Oshas guidelines, NABL certification & Accrediation, CFR 21 part11 , WHO- GMP...Oshas guidelines, NABL certification & Accrediation, CFR 21 part11 , WHO- GMP...
Oshas guidelines, NABL certification & Accrediation, CFR 21 part11 , WHO- GMP...
 
Demo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre AccreditationDemo of NABH Documentation Kit for Pre Accreditation
Demo of NABH Documentation Kit for Pre Accreditation
 
Qa tools and techniques
Qa tools and techniquesQa tools and techniques
Qa tools and techniques
 
concept of validation
concept of validationconcept of validation
concept of validation
 
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
“Pharmaceutical Quality Matrices in determining overall state of Quality and ...
 
Scott Buchheit RA Specialist Resume
Scott Buchheit RA Specialist ResumeScott Buchheit RA Specialist Resume
Scott Buchheit RA Specialist Resume
 
The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011The Minute: Volume 11 Issue 1 - Winter 2011
The Minute: Volume 11 Issue 1 - Winter 2011
 
Postmarket Surveillance Medical Devices
Postmarket Surveillance   Medical DevicesPostmarket Surveillance   Medical Devices
Postmarket Surveillance Medical Devices
 
Managing Reliability Expectations & Warranty Costs in Medical Electronics
Managing Reliability Expectations & Warranty Costs in Medical ElectronicsManaging Reliability Expectations & Warranty Costs in Medical Electronics
Managing Reliability Expectations & Warranty Costs in Medical Electronics
 
Critical Path Initiative Challenges
Critical  Path  Initiative  ChallengesCritical  Path  Initiative  Challenges
Critical Path Initiative Challenges
 
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...
 
Quality Management Systems (2).pdf
Quality Management Systems (2).pdfQuality Management Systems (2).pdf
Quality Management Systems (2).pdf
 
Four Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device TrialFour Practical Approaches To Managing A More Effective Device Trial
Four Practical Approaches To Managing A More Effective Device Trial
 
Introduction to validation
Introduction to validationIntroduction to validation
Introduction to validation
 
FDA Guidance and Clinical Trials
FDA Guidance and Clinical TrialsFDA Guidance and Clinical Trials
FDA Guidance and Clinical Trials
 

More from I3CGLOBAL

FDA 510k Pre Submission.pptx
FDA 510k Pre Submission.pptxFDA 510k Pre Submission.pptx
FDA 510k Pre Submission.pptx
I3CGLOBAL
 
New Medical Device Regulation in INDIA
New Medical Device Regulation in INDIANew Medical Device Regulation in INDIA
New Medical Device Regulation in INDIA
I3CGLOBAL
 
Cost of CE Marking
Cost of CE MarkingCost of CE Marking
Cost of CE Marking
I3CGLOBAL
 
ISO 13485
ISO 13485ISO 13485
ISO 13485
I3CGLOBAL
 
FDA 510K
FDA 510KFDA 510K
FDA 510K
I3CGLOBAL
 
CE Marking
CE MarkingCE Marking
CE Marking
I3CGLOBAL
 
Clean room
Clean roomClean room
Clean room
I3CGLOBAL
 

More from I3CGLOBAL (7)

FDA 510k Pre Submission.pptx
FDA 510k Pre Submission.pptxFDA 510k Pre Submission.pptx
FDA 510k Pre Submission.pptx
 
New Medical Device Regulation in INDIA
New Medical Device Regulation in INDIANew Medical Device Regulation in INDIA
New Medical Device Regulation in INDIA
 
Cost of CE Marking
Cost of CE MarkingCost of CE Marking
Cost of CE Marking
 
ISO 13485
ISO 13485ISO 13485
ISO 13485
 
FDA 510K
FDA 510KFDA 510K
FDA 510K
 
CE Marking
CE MarkingCE Marking
CE Marking
 
Clean room
Clean roomClean room
Clean room
 

Recently uploaded

Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
Dharma Homoeopathy
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
rightmanforbloodline
 
Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
patriciaava1998
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
Dr Rachana Gujar
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
Chandrima Spa Ajman
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
ChetanSharma78255
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
Azreen Aj
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Ear Solutions (ESPL)
 
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURYDR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
SHAMIN EABENSON
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
eurohealthleaders
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
aditigupta1117
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
Conference Panel
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
Dr Rachana Gujar
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
MuzafarBohio
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
R3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell Therapy: A New Hope for Women with Ovarian FailureR3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell
 
Pediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo HospitalPediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo Hospital
Apollo 24/7 Adult & Paediatric Emergency Services
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
DianaRodriguez639773
 

Recently uploaded (20)

Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
 
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...
 
Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
 
Luxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage CenterLuxurious Spa In Ajman Chandrima Massage Center
Luxurious Spa In Ajman Chandrima Massage Center
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
 
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURYDR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
 
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdfInnovative Minds France's Most Impactful Healthcare Leaders.pdf
Innovative Minds France's Most Impactful Healthcare Leaders.pdf
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
R3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell Therapy: A New Hope for Women with Ovarian FailureR3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
R3 Stem Cell Therapy: A New Hope for Women with Ovarian Failure
 
Pediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo HospitalPediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo Hospital
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGYTime line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
Time line.ppQAWSDRFTGYUIOPÑLKIUYTREWASDFTGY
 

Clinical Evaluation of Medical Devices

  • 1.
  • 2. CLINICAL EVALUATION Recent amendments made to the Medical Device Directive (MDD 93/42/EEC) state that every medical device affixing CE Logo, regardless of its classification, must have a clinical evaluation report in its Technical File / Design Dossier. The Directive’s specific focus on implantable or class III medical devices gives the false impression that clinical investigation does not apply to other Medical devices. This has led to the current situation where clinical trials are rarely done in the pre-market steps of medical devices development. With the implementation of Directive 2007/47/EC, clinical evaluation has become a central element of regulatory compliance under the Medical Device Directive and Active Implantable Medical Device Directive. Manufacturers of innovative technologies face the greatest impact, as they must present complete and sufficient clinical evaluation files to ensure timely assessment and favourable review of their products. BENEFITS OF CONDUCTING CLINICAL EVALUATION Regulatory conformance: Conforming to the regulatory framework is necessary and should be done in order to get Notified Body approval for Technical file followed by CE Certification. Choosing to perform a clinical investigation is the best answer to conform to the new requirements of the Medical Device Directive MDD 93/42/EEC. Early detection and resolution of safety issues: Over 25% of safety alerts are due to manufacturing defects. This high proportion demonstrates the importance of an early detection of potential safety issues. Early assessment gives the manufacturer time to take corrective action and to provide potential damages to the company’s reputation. Manufacturer Image: An early clinical investigation most often results in a positive image and greater usage of the product throughout the healthcare system. A well-designed clinical investigation based on a robust methodology gives a chance to publish a scientific article in a peer-reviewed journal.
  • 3. HOW TO FOLLOW STANDARD REQUIRMENT METHODOLOGY WHEN PERFORMING A CLINICAL EVALUATION The most important part lies in the methodology used. Any evaluation must be conducted following a strict adherence to regulatory requirements is the success of the clinical study. A proper methodology saves lot of time and success. APPOINT I 3 CONSULTING FOR BETTER NAVIGATION AND RESULTS Working early with I 3 Consulting for smooth and error free submission to Notified Bodies. Our project manager’s work with clients to ensure clinical evaluation was adequate and in line with intended use, labelling, equivalent devices and in conformance with MEDDev Guidelines. CLINICAL EVALUATION ANALYSIS OF CLINICIAL DATA by (a) Clinical investigation(s) of the device concerned (b) Studies reported in the scientific literature of a similar device (c) Published and/or unpublished reports on other clinical experience of either the device in question or a similar device POST MARKET a) Surveillance (PMS) b) Clinical Follow-up (PMCF) c) Residual Risk
  • 4. KNOW OUR FEES Complete our Quote Request Form for a detailed proposal. For more urgent requests, feel free to use our Website Skype link or direct dialling numbers to USA & India. Activity Class of Medical Device 1 1s/m 11a 11b 111 Guidance on MDD Requirements $ 50 $ 100 $ 150 $ 200 $ 250 Development of Protocol / Procedure $ 50 $ 50 $ 50 $ 50 $ 50 Clinical Evaluation & Documentation $ 300 $ 400 $ 500 $ 600 $ 700 Post Market Surveillance Procedure & Plan $ 100 $ 150 $ 200 $ 250 $ 300 Post Market clinical follow-up Procedure & Plan $ 100 $ 150 $ 200 $ 250 $ 300 GAP Analysis of Risk Management File $ 100 $ 150 $ 200 $ 250 $ 300 Vigilance Control & Related Forms $ 100 $ 100 $ 100 $ 100 $ 100 Taxes Extra GET A CUSTOMIZED PROPOSAL Complete our Quote Request Form for a detailed proposal. For more urgent requests, feel free to use our Website Skype link or direct dialling numbers to USA & India. CONTACT INFORMATION INDIA S8, J J PARK 02, 4 CROSS, BHAVANI NAGAR, CHRIST SCHOOL ROAD, S.G PALYA, BANGALORE – 560029 FAX + 91 804 160 8963 USA 2871 COASTAL DRIVE, AURORA mail to us ILLINOIS – 60503 FAX + 1 815 986 2632 www.i3cglobal.com TURKEY ANADOLU BULVARI GIMAT SITESI 3. BLOCK NO: 29 P06105 MUCUNKOY, ANKARA, TURKEY FAX + 90 312 397 0058